{"id":"W6902795405","doi":"10.7916/d8bv7f51","title":"Residual macrovascular risk in 2013: what have we learned?","year":2014,"lang":"en","type":"article","venue":"Columbia Academic Commons (Columbia University)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"H. Lundbeck A/S; Servier; Astellas Pharma; Novo Nordisk; International Atherosclerosis Society; Québec Consortium for Drug Discovery; Anthera; Regeneron Pharmaceuticals; Amarin Corporation; Boston Scientific Corporation; Genentech; Valeant Pharmaceuticals International; Daiichi Sankyo Europe; Kowa Company; Halozyme; Sanofi; GlaxoSmithKline; Eli Lilly and Company; AstraZeneca; Amylin Pharmaceuticals; Amgen; Pfizer","keywords":"Evolocumab; Atherosclerotic cardiovascular disease; Residual risk; Triglycerides blood; Disease","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.001915644,0.0002956915,0.00102151,0.0004414109,0.0005244119,0.0002337464,0.0006675899,0.0008070424,0.0005396075],"category_scores_gemma":[0.0002978943,0.0005021775,0.0005841032,0.001155684,0.0003181556,0.0006683682,0.0004578058,0.002628347,0.0001740655],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006235918,"about_ca_system_score_gemma":0.0003790114,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.07756595,"about_ca_topic_score_gemma":0.3046333,"domain_scores_codex":[0.9957408,0.0009775672,0.000541085,0.0009699628,0.0008116098,0.0009589573],"domain_scores_gemma":[0.9971844,0.0001999383,0.0002517932,0.001560791,0.0001740047,0.0006290795],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002678592,0.0003246402,0.7552279,0.0003348308,0.0005488088,0.0005368082,0.0007161266,0.0001404864,0.0001345227,0.0002301756,0.07561021,0.1659276],"study_design_scores_gemma":[0.006806091,0.0003139323,0.2340845,0.0007735821,0.0005802772,0.0001276549,0.002365493,0.0007856027,0.00003563629,0.0007224397,0.7527902,0.0006146127],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9766678,0.003452975,0.0003747568,0.003801452,0.0003572121,0.001665321,0.00003178051,0.0002768487,0.0133718],"genre_scores_gemma":[0.9212831,0.0249826,0.0004526187,0.0005232694,0.0005698717,0.00001658289,0.0000631555,0.0001067351,0.0520021],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6771799,"threshold_uncertainty_score":0.999743,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0181897569136022,"score_gpt":0.2351062886206532,"score_spread":0.2169165317070511,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}